1 active not recruiting, 1 recruiting, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Myeloid Neoplasm: new trials by email Literature Review of Myeloid Neoplasm trials Research Report on Myeloid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms Cladribine, Cytarabine, Mitoxantrone - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Recruiting | University of Washington | 62 | 2022-02-04 | 2026-04-17 |
| Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms Cladribine, Cytarabine, Recombinant Granulocyte Colony-Stimulating Factor - Myeloid Neoplasm, Recurrent Acute Myeloid Leukemia | Phase 1 | Terminated | University of Washington | 13 | 2020-05-08 | 2023-12-28 |
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Azacitidine, Pevonedistat, Venetoclax - Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 40 | 2019-02-27 | 2026-07-16 |
Leukemia, Myeloid, Acute (3) · Hypereosinophilic Syndrome (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Neutrophilic, Chronic (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Sarcoma, Myeloid (1) · Thrombocythemia, Essential (1) · Thrombocytosis (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Leukemia (3) · Leukemia, Myeloid (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Bone Marrow Diseases (1) · Bone Marrow Neoplasms (1) · Chronic Disease (1) · Disease Attributes (1) · Eosinophilia (1) · Hematologic Neoplasms (1) · Hemorrhagic Disorders (1)
Cladribine (2) · Cytarabine (2) · Mitoxantrone (2) · pegylated granulocyte colony-stimulating factor (2) · venetoclax (2) · Azacitidine (1) · pevonedistat (1)
University of Washington (2) · M.D. Anderson Cancer Center (1)
United States (3)
Mary-Beth M. Percival (1) · Mary-Beth Percival, MD (1) · Nicholas Short (1)